A strong association of gemcitabine to acute coronary syndrome (ACS) is not currently established in the literature. In this series, we highlight that both patients with gemcitabine-related ACS were more than 50 years old, had underlying coronary artery disease and suffered from metastatic cancer. However, further prospective studies are required to validate the significance of these observations.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8383679 | PMC |
http://dx.doi.org/10.14740/jmc3417 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!